Presenters: John A. Rock, MD; William D. Schlaff, MD; Deborah A. Metzger, PhD, MD
Implications of add-back therapy to the length of treatment with the GnRH agonists; The appropiate time to initiate add-back therapy on a patient being treated with GnRH agonists; Diseases which can be treated with add-back therapy; Candidate profile for add-back therapy.
|